| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |